Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Jason Chapnik DCBO Docebo Inc. 13D/A 64% 4mo
Dennis J. Wilson LULU lululemon athletica inc. 13D/A 8.6% 4mo
GAMCO INVESTORS, INC. ET AL LGL Lgl Group Inc 13D/A 0% 4mo
ORBIMED ADVISORS LLC QTTB Q32 Bio Inc. 13D/A 13.9% 4mo
BNDES Participacoes S.A. PBR Petrobras - Petroleo Brasileiro SA 13D/A 13.41% 4mo
L.I.A. Pure Capital Ltd. EVGN Evogene Ltd. 13D/A 16.81% 4mo
LINGTAO KONG RDGT Ridgetech Inc. 13D/A 3.2% 4mo
Fairmount Funds Management LLC CBIO Crescent Biopharma, Inc. 13D/A 16.5% 4mo
Velan Capital Investment Management LP JSPR Jasper Therapeutics, Inc. 13D/A 9.88% 4mo
Peter M. Hecht KRSA Korsana Biosciences, Inc. 13D/A 19.4% 4mo
Caddis Holdings, LP FRMI Fermi Inc. 13G 8.2% 4mo
The Hewlett Fund LP NVVE Nuvve Holding Corp. 13G 9.99% 4mo
Gonzalez Alejandro RZLV Rezolve Ai PLC 13G/A 7.5% 4mo
BIOTECHNOLOGY VALUE FUND L P RACD Research Alliance Corp IV 13G 6.4% 4mo
PERCEPTIVE ADVISORS LLC RACD Research Alliance Corp IV 13G 7.7% 4mo
Conversant Capital LLC NUAI New ERA Energy & Digital, Inc. 13G 5.3% 4mo
RichRich Capital LLC AGLT Agility Robotics, Inc. 13G 5.13% 4mo
RA CAPITAL MANAGEMENT, L.P. AGEN Agenus Inc 13G 9.9% 4mo
EcoR1 Capital, LLC ANRO Alto Neuroscience, Inc. 13G 5.8% 4mo
Lynx1 Capital Management LP DTIL Precision Biosciences Inc 13G 5.4% 4mo
MILLENNIUM MANAGEMENT LLC CATX Perspective Therapeutics, Inc. 13G 5.3% 4mo
NVIDIA CORP NBIS Nebius Group N.V. 13G 9.3% 4mo
Commodore Capital LP RACD Research Alliance Corp IV 13G 5.5% 4mo
Goldenwise Capital Group Ltd PHUN Phunware, Inc. 13D/A 6.9% 4mo
ReposiTrak, Inc. SGRP SPAR Group, Inc. 13D 31.4% 4mo
Ophir Asset Management Pty Ltd ITG ITG, Inc. 13G 7.9% 4mo
Aberdeen Group plc QURE uniQure N.V. 13G/A 4.52% 4mo
MILLENNIUM MANAGEMENT LLC MGNX Macrogenics Inc 13G/A 3.7% 4mo
MANGROVE PARTNERS IM, LLC CTAA Clearthink 1 Acquisition Corp. 13G 8.43% 4mo
Lei Wu GCT GigaCloud Technology Inc 13G/A 20% 4mo
MILLENNIUM MANAGEMENT LLC PHAT Phathom Pharmaceuticals, Inc. 13G/A 4.2% 4mo
MANGROVE PARTNERS IM, LLC CHPG ChampionsGate Acquisition Corp 13G/A 2.78% 4mo
FEDERATED HERMES, INC. SCYX Scynexis Inc 13G/A 4.03% 4mo
Hingham Institution for Savings CBNA Chain Bridge Bancorp Inc 13G 9.9% 4mo
Aberdeen Group plc CDXS Codexis, Inc. 13G/A 7.45% 4mo
Paisley Capital Holdings Corp CNXU Conexeu Sciences Inc. 13G 6.7% 4mo
Wentworth Funding, LLC BCG Binah Capital Group, Inc. 13G/A 5.3% 4mo
N.A.GLOBAL. CO. LTD. TOYO TOYO Co., Ltd 13G/A 4.9% 4mo
CVI Investments, Inc. CALC CalciMedica, Inc. 13G 5.1% 4mo
Lee Seng Chi FGL Founder Group Ltd 13D/A 6.24% 4mo
Thien Chiet Chai FGL Founder Group Ltd 13D 2.38% 4mo
Jialin Qu DRK DarkHorse Technologies Inc. 13G 6.2% 4mo
Emirates Telecommunications Group Company PJSC VOD Vodafone Group Public Ltd Co 13G/A 0% 4mo
CK Life Sciences Int'l., (Holdings) Inc. RNAZ Transcode Therapeutics, Inc. 13D/A 8.8% 4mo
Linden Advisors LP PLMK Plum Acquisition Corp. IV 13G 6.5% 4mo
Poplar Point Capital Management LLC TACT Transact Technologies Inc 13D 15.22% 4mo
GameStop Corp. EBAY Ebay Inc 13D/A 9.8% 4mo
ROTHBERG JONATHAN M BFLY Butterfly Network, Inc. 13D/A 0.4% 4mo
Inversiones Atlantida S.A. USCB Uscb Financial Holdings, Inc. 13G 8.2% 4mo
SQUADRA INVESTMENTS - GESTAO DE RECURSOS LTDA. INTR Inter & Co, Inc. 13G/A 9.8% 4mo